Whole Slide Imaging Market – Global Growth, Trends, and Forecasts 2019-2024 – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Whole
Slide Imaging Market – Growth, Trends, and Forecast (2019 – 2024)”
report has been added to ResearchAndMarkets.com’s
offering.

The key factors propelling the whole slide imaging market are increasing
usage in drug discovery processes, technological advancements in whole
slide imaging, and rising popularity of virtual slides, as compared to
physical slides. Also, the increasing incidence of cancer is expected to
drive the growth of the overall market.

With increasing research, there are many pharmaceutical and biotech
companies that have made significant investments in drug discovery. As a
consequence, imaging is now performed in all drug discovery processes.
Therefore, imaging and image-based technologies are now commonplace
across the drug discovery workflow and hold great promise for R&D,
allowing researchers to understand and work with model organisms. Thus,
it is expected to improve standardization, quality, and manageability of
research, and help reduce costs. Thus, as research in drug discovery
increases, it is expected to directly impact the growth of the whole
slide imaging market.

Digital pathology (DP) is also a rapidly growing field that has
generated a lot of interest among hospitals, laboratories, surgeons,
research institutes, and healthcare companies, among others. The digital
pathology process is expected to significantly increase, and thereby,
increase productivity and efficiency, by allowing pathologists to stay
in their offices rather than travel to numerous locations.

With the advancement of digital pathology and computer-assisted
artificial intelligence technology, it is inevitable that digital health
will come to play an important role in the strategic planning of cancer
research and precision medicine delivery.

Thus, whole slide imaging devices are increasingly being used for cancer
research and precision medicine, as many diseases can be defined by
being examined under the microscope. Pathologists’ involvement in
precision medicine and digital technology is likely to be a key driver
for improving patient care. As a result, this is a great opportunity for
the growth of the market.

Scope of the Report

As per the scope of the report, whole slide imaging involves physical
slides, which are transformed into digital resources that can be
analyzed on any computer, easily stored, and quickly shared with
colleagues wherever they are. It refers to the scanning of conventional
glass slides, in order to produce digital slides, and is the most recent
imaging modality being employed by pathology departments, worldwide.

Key Market Trends

Immunohistochemistry Application Segment is Expected to Grow the Fastest
During the Forecast Period

Immunohistochemistry (IHC) is a method for detecting antigens or haptens
in the cells of a tissue section, by using the principle of antibodies
binding specifically to antigens in biological tissues. It is a widely
used technique in pathology to observe protein expression in tissue
samples. It is also gaining importance, as many biotech companies use
immunohistochemistry in early research and later stage drug development.
Thus, with more advanced processes, this method helps in faster
assessment of samples.

There has also been increased use of whole slide imaging to study blood
coagulation disorders to hematopoietic neoplasms. Although there has
been increased interest by pharmaceutical companies to use WSI products
to develop biomarkers, the acceptance of digitized images in clinical
validation studies by regulatory authorities still remains a challenge.

The Asia-Pacific Market Holds the Fastest Growth, and is
Expected to Follow the Same Trend over the Forecast Period

The Asia-Pacific market is witnessing the highest CAGR, owing to the
same factors responsible for the growth of this market, such as
increasing research on drug discovery and awareness about the benefits
of WSI. The market for whole slide imaging is growing every year and
generating a large number of pathology specimens each year, due to the
presence of a large population base. Thus, the adoption rate of whole
slide imaging in the region has also increased, and is expected to rise
in the same manner over the coming years.

Competitive Landscape

In the last decade, many pharmaceutical and biotech companies made
significant investments in imaging in drug discovery. There has also
been increased interest by pharmaceutical companies to use WSI products
to develop biomarkers, companion, or complementary diagnostics. Many
manufacturing companies are, thus, looking for opportunities in
different market economies, such as Europe and Canada, where the
policies are not as stringent and are better integrated.

Key Topics Covered:

1 Introduction

2 Research Methodology

3 Executive Summary

4 Market Dynamics
4.1 Market Overview
4.2
Market Drivers
4.2.1 Growing Popularity of Virtual Slides as
Compared to Physical Slides
4.2.2 Technological Advancements in
Whole Slide Imaging
4.2.3 Increasing Research in Drug Discovery
4.3
Market Restraints
4.3.1 Stringent Regulatory Approvals
4.3.2
High Cost of Whole Slide Imaging Systems
4.4 Porter’s Five Forces
Analysis

5 Market Segmentation
5.1 By Technology
5.1.1
Scanners
5.1.2 IT Infrastructure
5.1.3 Viewer
5.1.4 Image
Management System
5.2 By Application
5.2.1 Telepathology
5.2.2
Cytopathology
5.2.3 Immunohistochemistry
5.2.4 Hematopathology
5.3
By End User
5.3.1 Education
5.3.2 Research
5.3.3 Clinical
5.4
Geography

6 Competitive Landscape
6.1 Company Profiles
6.1.1
Olympus Corporation
6.1.2 Philips Healthcare
6.1.3 Definiens AG
6.1.4
Leica Microsystems GmbH
6.1.5 Ventana Medical Systems Inc.
6.1.6
Nikon Corporation
6.1.7 Visiopharm
6.1.8 3Dhistech
6.1.9
Hamamatsu Photonics KK
6.1.10 Indica Labs
6.1.11 Inspirata
6.1.12
Mikroscan Technologies Inc.

7 Market Opportunities and Future Trends

For more information about this report visit https://www.researchandmarkets.com/research/4pjncn/whole_slide?w=4

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
[email protected]
For
E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call
1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related
Topics: Laboratory
Testing